DexCom Aktie
WKN: A0D9T1 / ISIN: US2521311074
02.08.2019 14:30:00
|
Dexcom Announces Upcoming Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:
- Quentin Blackford, Executive Vice President and Chief Financial Officer, and Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present at the 39th Annual Canaccord Genuity Growth Conference in Boston, MA, on Wednesday, August 7th, 2019 at 2:00 PM (ET). The presentation, which will occur live at the InterContinental Boston Hotel, will be concurrently webcast.
- Quentin Blackford, Executive Vice President and Chief Financial Officer, will present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York, NY, on Monday, September 9th, 2019 at 9:55 AM (ET). The presentation, which will occur live at the Grand Hyatt New York, will be concurrently webcast.
The link to the webcast will be available on the Dexcom website at www.dexcom.com by navigating to "About Us,” then "Investor Relations,” and finally "Events and Presentations” and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for use by people with diabetes and by healthcare providers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190802005092/en/

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DexCom Inc.mehr Nachrichten
06.05.25 |
NASDAQ 100-Handel aktuell: NASDAQ 100 beendet die Sitzung mit Verlusten (finanzen.at) | |
06.05.25 |
Schwacher Wochentag in New York: So bewegt sich der NASDAQ 100 nachmittags (finanzen.at) | |
06.05.25 |
Handel in New York: NASDAQ 100 in der Verlustzone (finanzen.at) | |
06.05.25 |
NASDAQ Composite Index-Papier DexCom-Aktie: So viel hätten Anleger mit einem Investment in DexCom von vor 5 Jahren verloren (finanzen.at) | |
02.05.25 |
Gewinne in New York: Schlussendlich Pluszeichen im NASDAQ 100 (finanzen.at) | |
02.05.25 |
Freundlicher Handel in New York: NASDAQ Composite zum Handelsende mit Zuschlägen (finanzen.at) | |
02.05.25 |
Freundlicher Handel in New York: S&P 500 liegt letztendlich im Plus (finanzen.at) | |
02.05.25 |
Gute Stimmung in New York: So steht der NASDAQ Composite am Nachmittag (finanzen.at) |
Analysen zu DexCom Inc.mehr Analysen
Aktien in diesem Artikel
DexCom Inc. | 73,21 | 1,62% |
|